Table 5. Summary of the binding of the HLDA10 panel to three AML samples.
Code | Molecule | AML 1 | AML 2 | AML 3 |
---|---|---|---|---|
10-02 | DNGR-1 | +/− | + | − |
10-15 | Flt-3 | +/− | ++ | +/− |
10-17 | CLEC12A | ND | ++ | +/− |
10-20 | Unknown | + | +/− | + |
10-24 | TIM-3 | ++ | ++ | ++ |
10-27 | Unknown | ++ | +/− | ++ |
10-33 | Unknown | ++ | ++ | ++ |
10-43 | CD245 | +/− | +/− | + |
10-45 | CLEC9A | +/− | ++ | − |
10-51 | CLEC12A | +/− | ++ | +/− |
10-52 | ULBP-3 | + | ++ | − |
10-53 | IL-1RACP | ++ | ++ | ++ |
10-54 | CLEC13A | +/− | ++ | − |
10-65 | CLEC9A | +/− | + | − |
10-70 | P2X7 | + | ++ | +/− |
10-73 | CLEC12A | +/− | ++ | + |
10-75 | TIM-3 | ++ | ++ | + |
Abbreviations: AML, acute myeloid leukaemia; HLDA10, Tenth Human Leukocyte Differentiation Antigen.